RxDoctor Payments Data

Emily Leidig

Adult Health · Bristol, TNNPI 1841807625

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $14,250 of the $16,544 with a category attached, or 86.1%. ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) accounts for 91.5% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $14,967 and has fallen 98.5% since, to $219 in 2025. Among adult health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,544in general payments, 2019–2025

Across 130 payments — averaging $127.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$15K
  • Novartis$488
  • Pfizer$167
  • AstraZeneca$115
  • Amgen$86
  • Abiomed$85
  • plus $463 from 13 others

What the payments were for

  • Speaking & faculty fees$14,25086%
  • Food & beverage$2,29414%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,544 in reported general payments places this provider in the 95th percentile of 352 adult health providers in Tennessee.

See all adult health providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban82$87,995
OzempicSemaglutide69$84,634
JardianceEmpagliflozin24$24,406
XareltoRivaroxaban23$24,347
FarxigaDapagliflozin Propanediol14$23,189
RybelsusSemaglutide13$19,714
MounjaroTirzepatide17$17,329
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$17,281
VascepaIcosapent Ethyl11$6,993
SymbicortBudesonide/Formoterol Fumarate23$5,346
LantusInsulin Glargine,hum.Rec.Anlog14$3,368
Omeprazole171$3,049
Duloxetine Hcl87$2,395
Albuterol Sulfate HfaAlbuterol Sulfate118$2,373
Gabapentin112$1,803

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$77$104,34782 claims
PfizerEliquis$167$87,99582 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$115$45,81664 claims
Boehringer IngelheimJardiance$45$24,40624 claims
Johnson & JohnsonXarelto$79$24,34723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 352 adult health providers in Tennessee.

Other adult health in Bristol

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →